2-methyl-6-[2-(3-methylphenyl)-3H-benzimidazol-5-yl]-1H-benzimidazole;2-methyl-6-[2-(4-methylphenyl)-3H-benzimidazol-5-yl]-1H-benzimidazole;2-methyl-6-[[2-(4-methylphenyl)-3H-benzimidazol-5-yl]sulfonyl]-1H-benzimidazole;2-methyl-6-[2-(3-methylphenyl)-1,3-benzothiazol-6-yl]-1,3-benzothiazole;2-methyl-6-[2-(4-methylphenyl)-1,3-benzothiazol-6-yl]-1,3-benzothiazole;2-methyl-6-[2-(3-methylphenyl)-1,3-benzoxazol-6-yl]-1,3-benzoxazole;2-methyl-6-[2-(4-methylphenyl)-1,3-benzoxazol-6-yl]-1,3-benzoxazole
C154H118N20O6S5 — CID 158093267
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-methyl-6-[2-(3-methylphenyl)-3H-benzimidazol-5-yl]-1H-benzimidazole;2-methyl-6-[2-(4-methylphenyl)-3H-benzimidazol-5-yl]-1H-benzimidazole;2-methyl-6-[[2-(4-methylphenyl)-3H-benzimidazol-5-yl]sulfonyl]-1H-benzimidazole;2-methyl-6-[2-(3-methylphenyl)-1,3-benzothiazol-6-yl]-1,3-benzothiazole;2-methyl-6-[2-(4-methylphenyl)-1,3-benzothiazol-6-yl]-1,3-benzothiazole;2-methyl-6-[2-(3-methylphenyl)-1,3-benzoxazol-6-yl]-1,3-benzoxazole;2-methyl-6-[2-(4-methylphenyl)-1,3-benzoxazol-6-yl]-1,3-benzoxazole
2-methyl-6-[2-(3-methylphenyl)-3H-benzimidazol-5-yl]-1H-benzimidazole;2-methyl-6-[2-(4-methylphenyl)-3H-benzimidazol-5-yl]-1H-benzimidazole;2-methyl-6-[[2-(4-methylphenyl)-3H-benzimidazol-5-yl]sulfonyl]-1H-benzimidazole;2-methyl-6-[2-(3-methylphenyl)-1,3-benzothiazol-6-yl]-1,3-benzothiazole;2-methyl-6-[2-(4-methylphenyl)-1,3-benzothiazol-6-yl]-1,3-benzothiazole;2-methyl-6-[2-(3-methylphenyl)-1,3-benzoxazol-6-yl]-1,3-benzoxazole;2-methyl-6-[2-(4-methylphenyl)-1,3-benzoxazol-6-yl]-1,3-benzoxazole (PubChem CID 158093267) has the molecular formula C154H118N20O6S5 and a molecular weight of 2505.11 g/mol. Its IUPAC name is 2-methyl-6-[2-(3-methylphenyl)-3H-benzimidazol-5-yl]-1H-benzimidazole;2-methyl-6-[2-(4-methylphenyl)-3H-benzimidazol-5-yl]-1H-benzimidazole;2-methyl-6-[[2-(4-methylphenyl)-3H-benzimidazol-5-yl]sulfonyl]-1H-benzimidazole;2-methyl-6-[2-(3-methylphenyl)-1,3-benzothiazol-6-yl]-1,3-benzothiazole;2-methyl-6-[2-(4-methylphenyl)-1,3-benzothiazol-6-yl]-1,3-benzothiazole;2-methyl-6-[2-(3-methylphenyl)-1,3-benzoxazol-6-yl]-1,3-benzoxazole;2-methyl-6-[2-(4-methylphenyl)-1,3-benzoxazol-6-yl]-1,3-benzoxazole.
Molecular Properties
| Compound Name | 2-methyl-6-[2-(3-methylphenyl)-3H-benzimidazol-5-yl]-1H-benzimidazole;2-methyl-6-[2-(4-methylphenyl)-3H-benzimidazol-5-yl]-1H-benzimidazole;2-methyl-6-[[2-(4-methylphenyl)-3H-benzimidazol-5-yl]sulfonyl]-1H-benzimidazole;2-methyl-6-[2-(3-methylphenyl)-1,3-benzothiazol-6-yl]-1,3-benzothiazole;2-methyl-6-[2-(4-methylphenyl)-1,3-benzothiazol-6-yl]-1,3-benzothiazole;2-methyl-6-[2-(3-methylphenyl)-1,3-benzoxazol-6-yl]-1,3-benzoxazole;2-methyl-6-[2-(4-methylphenyl)-1,3-benzoxazol-6-yl]-1,3-benzoxazole |
|---|---|
| PubChem CID | 158093267 |
| Molecular Formula | C154H118N20O6S5 |
| Molecular Weight | 2505.11 g/mol |
| Exact Mass | 2502.81 |
| IUPAC Name | 2-methyl-6-[2-(3-methylphenyl)-3H-benzimidazol-5-yl]-1H-benzimidazole;2-methyl-6-[2-(4-methylphenyl)-3H-benzimidazol-5-yl]-1H-benzimidazole;2-methyl-6-[[2-(4-methylphenyl)-3H-benzimidazol-5-yl]sulfonyl]-1H-benzimidazole;2-methyl-6-[2-(3-methylphenyl)-1,3-benzothiazol-6-yl]-1,3-benzothiazole;2-methyl-6-[2-(4-methylphenyl)-1,3-benzothiazol-6-yl]-1,3-benzothiazole;2-methyl-6-[2-(3-methylphenyl)-1,3-benzoxazol-6-yl]-1,3-benzoxazole;2-methyl-6-[2-(4-methylphenyl)-1,3-benzoxazol-6-yl]-1,3-benzoxazole |
| SMILES | Cc1ccc(-c2nc3ccc(-c4ccc5nc(C)[nH]c5c4)cc3[nH]2)cc1.Cc1ccc(-c2nc3ccc(-c4ccc5nc(C)oc5c4)cc3o2)cc1.Cc1ccc(-c2nc3ccc(-c4ccc5nc(C)sc5c4)cc3s2)cc1.Cc1ccc(-c2nc3ccc(S(=O)(=O)c4ccc5nc(C)[nH]c5c4)cc3[nH]2)cc1.Cc1cccc(-c2nc3ccc(-c4ccc5nc(C)[nH]c5c4)cc3[nH]2)c1.Cc1cccc(-c2nc3ccc(-c4ccc5nc(C)oc5c4)cc3o2)c1.Cc1cccc(-c2nc3ccc(-c4ccc5nc(C)sc5c4)cc3s2)c1 |
| InChI | InChI=1S/C22H18N4O2S.2C22H18N4.2C22H16N2O2.2C22H16N2S2/c1-13-3-5-15(6-4-13)22-25-19-10-8-17(12-21(19)26-22)29(27,28)16-7-9-18-20(11-16)24-14(2)23-18;1-13-3-5-15(6-4-13)22-25-19-10-8-17(12-21(19)26-22)16-7-9-18-20(11-16)24-14(2)23-18;1-13-4-3-5-17(10-13)22-25-19-9-7-16(12-21(19)26-22)15-6-8-18-20(11-15)24-14(2)23-18;1-13-3-5-15(6-4-13)22-24-19-10-8-17(12-21(19)26-22)16-7-9-18-20(11-16)25-14(2)23-18;1-13-4-3-5-17(10-13)22-24-19-9-7-16(12-21(19)26-22)15-6-8-18-20(11-15)25-14(2)23-18;1-13-3-5-15(6-4-13)22-24-19-10-8-17(12-21(19)26-22)16-7-9-18-20(11-16)25-14(2)23-18;1-13-4-3-5-17(10-13)22-24-19-9-7-16(12-21(19)26-22)15-6-8-18-20(11-15)25-14(2)23-18/h3-12H,1-2H3,(H,23,24)(H,25,26);2*3-12H,1-2H3,(H,23,24)(H,25,26);4*3-12H,1-2H3 |
| InChIKey | FOJAPCWOMZHKLR-UHFFFAOYSA-N |
| XLogP | 40.89 |
| TPSA | 361.90 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 24 |
| Rotatable Bonds | 15 |
| Heavy Atoms | 185 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2505.11 |
| LogP ≤ 5 | 40.89 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 24 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158093267 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.